Research on colorectal carcinomas has revealed that the expression level of MX1 in tumors with lymph node metastases (UICC stage III) is higher than that in tumors without lymph node metastases (UICC stage II) [68]. Here, MX1 is linked to metastatic malignant neoplasm in the lymph nodes.